Jeffrey Yordon - Jul 20, 2022 Form 4 Insider Report for Athenex, Inc. (ATNXQ)

Role
COO, and President, Athenex Pharmaceutical Division. Exhibit List: Exhibit 24.1 - Power of Attorney
Signature
/s/Staci Holquist, Attorney-in-Fact
Stock symbol
ATNXQ
Transactions as of
Jul 20, 2022
Transactions value $
$0
Form type
4
Date filed
7/21/2022, 05:40 PM
Previous filing
Aug 5, 2021
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNXQ Common Stock 237K Jul 20, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNXQ Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jul 20, 2022 Common Stock 150K $0.67 Direct F6
holding ATNXQ Stock Option (Right to Buy) 150K Jul 20, 2022 Common Stock 150K $9.00 Direct
holding ATNXQ Stock Option (Right to Buy) 212K Jul 20, 2022 Common Stock 212K $11.00 Direct
holding ATNXQ Stock Option (Right to Buy) 100K Jul 20, 2022 Common Stock 100K $17.30 Direct
holding ATNXQ Stock Option (Right to Buy) 100K Jul 20, 2022 Common Stock 100K $13.17 Direct F1
holding ATNXQ Stock Option (Right to Buy) 100K Jul 20, 2022 Common Stock 100K $12.45 Direct F2
holding ATNXQ Stock Option (Right to Buy) 50K Jul 20, 2022 Common Stock 50K $3.80 Direct F3
holding ATNXQ Restricted Stock Units 50K Jul 20, 2022 Common Stock 50K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in four equal annual installments beginning on February 28, 2020.
F2 This option vests in four equal annual installments beginning on June 5, 2021.
F3 This option vests in four equal annual installments beginning on August 3, 2022.
F4 Each restricted stock unit represents a contingent right to receive one share of stock.
F5 The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
F6 This option vests in four equal annual installments beginning on July 20, 2023.

Remarks:

COO, and President, Athenex Pharmaceutical Division. Exhibit List: Exhibit 24.1 - Power of Attorney